Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Gabelli Healthcare & Wellness Trust | GRX | Nov 21, 2024 | 10.10 | -0.20 |
The Gdl Fund | GDL | Nov 21, 2024 | 8.07 | -0.12 |
The Glimpse Group | VRAR | Nov 21, 2024 | 0.61 | +0.36 |
The Hackett Group | HCKT | Nov 21, 2024 | 30.68 | +0.43 |
The Hain Celestial Group | HAIN | Nov 21, 2024 | 8.05 | +8.49 |
The Hershey | HSY | Nov 21, 2024 | 174.95 | +0.55 |
The Herzfeld Caribbean Basin Fund | CUBA | Nov 21, 2024 | 2.44 | 0.00 |
The Honest Company | HNST | Nov 21, 2024 | 7.65 | +5.52 |
The Intergroup | INTG | Nov 21, 2024 | 13.98 | -0.29 |
The J.M Smucker Company | SJM | Nov 21, 2024 | 113.89 | +1.61 |
The Joint | JYNT | Nov 21, 2024 | 11.57 | +1.94 |
The Marygold Companies | MGLD | Nov 21, 2024 | 1.55 | +29.17 |
The ODP | ODP | Nov 21, 2024 | 26.63 | +2.98 |
The OLB Group | OLB | Nov 21, 2024 | 1.98 | +22.22 |
The Oncology Institute | TOI | Nov 21, 2024 | 0.16 | +17.25 |
The ONE Group Hospitality | STKS | Nov 21, 2024 | 3.30 | +6.80 |
The Pennant Group | PNTG | Nov 21, 2024 | 30.50 | -0.91 |
The Real Brokerage | REAX | Nov 21, 2024 | 5.22 | +5.88 |
The Real Estate Select Sector SPDR Fund | XLRE | Nov 21, 2024 | 43.76 | +0.67 |
The RealReal | REAL | Nov 21, 2024 | 4.48 | +1.13 |
The RMR Group A | RMR | Nov 21, 2024 | 22.15 | +0.82 |
The Shyft Group | SHYF | Nov 21, 2024 | 13.28 | -1.04 |
The Trade Desk A | TTD | Nov 21, 2024 | 127.35 | +2.78 |
The9 ADR | NCTY | Nov 21, 2024 | 10.56 | -3.83 |
TherapeuticsMD | TXMD | Nov 21, 2024 | 1.33 | -0.75 |
Theratechnologies | THTX | Nov 21, 2024 | 1.21 | -0.82 |
Theravance Biopharma | TBPH | Nov 21, 2024 | 9.61 | -3.61 |
Theriva Biologics | TOVX | Nov 21, 2024 | 1.28 | +1.59 |
Thermo Fisher Scientific | TMO | Nov 21, 2024 | 516.10 | +0.64 |
Thermon Group | THR | Nov 21, 2024 | 31.18 | +1.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.